PubMed:9398080 / 910-1087 JSONTXT

Annnotations TAB JSON ListView MergeView

    GlyCosmos15-UBERON

    {"project":"GlyCosmos15-UBERON","denotations":[{"id":"T7","span":{"begin":64,"end":69},"obj":"Body_part"},{"id":"T8","span":{"begin":121,"end":136},"obj":"Body_part"}],"attributes":[{"id":"A7","pred":"uberon_id","subj":"T7","obj":"http://purl.obolibrary.org/obo/GO_0005794"},{"id":"A8","pred":"uberon_id","subj":"T8","obj":"http://purl.obolibrary.org/obo/GO_0005886"}],"text":"In contrast, when cells were treated with brefeldin A (BFA) the Golgi markers were shifted to higher density but not the plasma membrane markers or the main peak of SM synthase."}

    GlyCosmos15-Sentences

    {"project":"GlyCosmos15-Sentences","blocks":[{"id":"T6","span":{"begin":0,"end":177},"obj":"Sentence"}],"text":"In contrast, when cells were treated with brefeldin A (BFA) the Golgi markers were shifted to higher density but not the plasma membrane markers or the main peak of SM synthase."}

    Anatomy-UBERON

    {"project":"Anatomy-UBERON","denotations":[{"id":"T7","span":{"begin":64,"end":69},"obj":"Body_part"},{"id":"T8","span":{"begin":121,"end":136},"obj":"Body_part"}],"attributes":[{"id":"A7","pred":"uberon_id","subj":"T7","obj":"http://purl.obolibrary.org/obo/GO_0005794"},{"id":"A8","pred":"uberon_id","subj":"T8","obj":"http://purl.obolibrary.org/obo/GO_0005886"}],"text":"In contrast, when cells were treated with brefeldin A (BFA) the Golgi markers were shifted to higher density but not the plasma membrane markers or the main peak of SM synthase."}